Privia Health Group Inc. (PRVA)
NASDAQ: PRVA
· Real-Time Price · USD
22.75
0.20 (0.89%)
At close: May 30, 2025, 3:59 PM
22.76
0.05%
After-hours: May 30, 2025, 04:21 PM EDT
Privia Health Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
|---|---|---|---|---|
| Capitated Revenue Revenue | 212.99M | 338.73M | 218.46M | 36.5M |
| Capitated Revenue Revenue Growth | -37.12% | +55.05% | +498.48% | n/a |
| Care Management Fee (PMPM) Revenue | 64.07M | 50.52M | 35.54M | 68.81M |
| Care Management Fee (PMPM) Revenue Growth | +26.82% | +42.14% | -48.35% | n/a |
| FFS-Administrative Services Revenue | 125.43M | 113.15M | 94.93M | 772.48M |
| FFS-Administrative Services Revenue Growth | +10.85% | +19.20% | -87.71% | n/a |
| FFS-Patient Care Revenue | 1.15B | 976.69M | 869.16M | 5.41M |
| FFS-Patient Care Revenue Growth | +17.35% | +12.37% | +15954.03% | n/a |
| Other Revenue Revenue | 8.55M | 8.5M | 5.95M | 83.02M |
| Other Revenue Revenue Growth | +0.52% | +43.00% | -92.84% | n/a |
| Shared Savings Revenue | 179.2M | 170.14M | 132.62M | n/a |
| Shared Savings Revenue Growth | +5.32% | +28.30% | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 38.64M | 40.89M | 37.74M | 35.77M | 38.21M | 35.85M | 34.47M | 32.76M | 31.24M | 33.33M | 37.31M | 37.93M | 40.77M | 43.12M | 38.5M | 179.84M | 17.18M | 18.78M | 12.5M | 10.64M | 13.44M |
| Selling, General, and Administrative Revenue Growth | -5.49% | +8.33% | +5.52% | -6.38% | +6.57% | +4.00% | +5.20% | +4.89% | -6.28% | -10.66% | -1.63% | -6.98% | -5.45% | +12.01% | -78.59% | +946.77% | -8.53% | +50.29% | +17.46% | -20.85% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales and Marketing Revenue | 6.92M | 6.46M | 7.05M | 6.85M | 6.08M | 6.25M | 7.24M | 5.96M | 5.29M | 5.17M | 5.09M | 4.82M | 4.66M | 3.8M | 4.59M | 11.18M | 3.18M | 3.96M | 2.71M | 2.22M | 2.45M |
| Sales and Marketing Revenue Growth | +7.12% | -8.30% | +2.85% | +12.60% | -2.62% | -13.70% | +21.57% | +12.67% | +2.18% | +1.67% | +5.58% | +3.39% | +22.66% | -17.18% | -58.96% | +251.07% | -19.64% | +46.25% | +22.03% | -9.46% | n/a |